Research offering unprecedented insights into global vaccine distribution patterns has found significant disparities in COVID-19 vaccination accessibility—identifying “vaccine deserts” in both high- and low-income countries. The work is published in the journal BMJ Global Health.
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV prevention drug lenacapavir allows it to persist in the body for up to a year. In their paper published in The Lancet journal, the group describes how they injected the new formulation into several HIV-free volunteers and tested them for up to a year, and what they found in doing so.
Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is one of the most aggressive forms of skin cancer, with current therapies—including immunotherapy and targeted drugs—showing limited effectiveness.
Not long after a threatening organism enters our bodies, our immune system springs into action and starts producing proteins known as type one interferons (IFN-I), which fight viruses and cancer, while also playing pathogenic roles in autoimmune disorders.
In the last few years, there has been a shift in the way we view salt when it comes to our health.
For decades, sport coaching has been built on the idea that there is “one correct way” to perform a skill.
Research increasingly shows that tackling modifiable exposures and environmental risks could be one of our most powerful levers for longevity and health span.
“No one expects a grown woman in her 40s to have an eating disorder. That’s for teenagers, right? Well, guess what—it happened to me.”
Two key federal advisory committees on food safety have been shut down, raising concerns among food safety advocates.
MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening. Until now, however, the precise cause of the condition was unknown.